Last reviewed · How we verify
Adcal-D3
At a glance
| Generic name | Adcal-D3 |
|---|---|
| Sponsor | Takeda |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adcal-D3 CI brief — competitive landscape report
- Adcal-D3 updates RSS · CI watch RSS
- Takeda portfolio CI